Zeit | Nachrichten Sprache:
Alle DE EN | Leser | Medien | ||
---|---|---|---|---|---|
07.02.23 | Accsys Technologies - Stronger than expected revenue growth in Q3 | 602 | Edison Investment Research | Accsys showed strong revenue growth of 32% in 9M23, driven by higher sales prices (to mitigate input pressure) and a recovery in volumes in Q323 compared to H123. The company remains positive about... ► Artikel lesen | |
07.02.23 | Vection Technologies - Space Travel in the Metaverse | 328 | Edison Investment Research | Vection Technologies (VR1) reported A$4.6m in Q223 receipts, up A$0.2m q-o-q. Recent announcements of the company's selection to develop virtual reality (VR) and metaverse technologies to promote space... ► Artikel lesen | |
07.02.23 | Filtronic - Component shortages causing delivery delays | 338 | Edison Investment Research | As flagged in Filtronic's January trading update, demand for 5G mobile communications infrastructure and work for new customers drove 5% year-on-year revenue growth during H123. However, shortages of... ► Artikel lesen | |
07.02.23 | Foxtons Group - Growth-oriented review poised to be announced | 499 | Edison Investment Research | FY22 was a robust year for Foxtons with revenue up 11%, but the short-term outlook is less certain for recessionary reasons. However, the outlook remains encouraging with the new CEO on the cusp of... ► Artikel lesen | |
07.02.23 | Numis - Revenues running in line with H222 | 273 | Edison Investment Research | The trends seen in Numis's H222 have continued in the first four months of FY23. Capital markets activity and revenues have been subdued but the strong momentum in M&A advisory has also been maintained... ► Artikel lesen | |
07.02.23 | Ebiquity - Strong revenue growth and improving margin | 372 | Edison Investment Research | Ebiquity's year-end trading update confirms that revenue continued to grow strongly in H222, delivering a 20% improvement for the full year, with underlying organic growth of 9%. Management is guiding... ► Artikel lesen | |
07.02.23 | Respiri - Dollars in the bank with CMS reimbursement | 335 | Edison Investment Research | In a positive development for its US commercial strategy, Respiri has announced receipt of its first reimbursement claims from the Centers for Medicare and Medicaid Services (CMS) for its wheezo remote... ► Artikel lesen |
Suchbegriffe der letzen 24 h | Anzahl |
---|---|
GAMESTOP | 340 |
EVOTEC | 310 |
TUI | 225 |
NVIDIA | 188 |
DEUTSCHE BANK | 182 |
BAYER | 169 |
PLUG POWER | 152 |
NEL | 140 |
RHEINMETALL | 139 |
SIEMENS ENERGY | 120 |
COMMERZBANK | 113 |
BARRICK GOLD | 112 |
BASF | 110 |
TESLA | 109 |
RWE | 99 |
VOLKSWAGEN | 99 |
BYD | 95 |
DEUTSCHE LUFTHANSA | 90 |
ALLIANZ | 89 |
DEUTSCHE TELEKOM | 87 |
MERCEDES-BENZ | 86 |
RENK GROUP | 82 |
HEIDELBERGER DRUCK | 79 |
E.ON | 78 |
AIXTRON SE | 76 |